top of page

Orange Biomed is a Healthcare Startup With Cutting-Edge Diabetes Management Technology.

Orange Biomed Press Coverage

company updates

Orange Biomed Company Updates

_Orange Biomed Established a Corporate R&D Center (2021).png

Orange Biomed Established a Corporate R&D Center (2021)


 

Orange Biomed Raises Seed Funding from institutional investors (2021).png

Orange Biomed Raises Seed Funding from Institutional Investors (2021)

Orange Biomed Receives Institutional Review Board Approval and Raises Pre-A Funding (2022)

Orange Biomed Receives Institutional Review Board Approval and Raises Pre-A Funding (2022)
 

Orange Biomed Secures Strategic investment from established Manufacturer (2022).png

Orange Biomed Secures Strategic Investment from Established Manufacturer (2022)

Orange Biomed receives Government grants for prospective biomedical technology (2021).png

Orange Biomed Receives Government Grants for Prospective Biomedical Technology (2021)

 

Orange Biomed Completes Prototype Development (2022).png

Orange Biomed Completes Prototype Development (2022)
 

Orange Biomed Receives 1st Patent (2022).png

Orange Biomed Receives 1st Patent (2022)


 

Orange Biomed Signs a Clinical Trial Agreement with Seoul Asan Medical Center (Hyundai gro

Orange Biomed Signs a Clinical Trial Agreement with Seoul Asan Medical Center (Hyundai group) (2021)
 

Orange Biomed Completes 1st Clinical Trial with Seoul Asan Medical Center (2022).png

Orange Biomed Completes 1st Clinical Trial with Seoul Asan Medical Center (2022)
 

Orange Biomed Files comprehensive U.S and international patents (2022).png

Orange Biomed Files Comprehensive U.S. and International Patients (2022)
 

bottom of page